What is the treatment for a suspected acetaminophen (Tylenol) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acetaminophen (Tylenol) Overdose

Administer N-acetylcysteine (NAC) immediately to any patient with suspected acetaminophen overdose—do not wait for laboratory confirmation if the ingestion occurred within 24 hours, as treatment within 8 hours prevents severe hepatotoxicity in 97% of cases. 1

Immediate Actions (Do Not Delay)

  • Start NAC immediately if the patient presents within 24 hours of ingestion, regardless of acetaminophen level results 2
  • Administer activated charcoal 1 g/kg orally if the patient presents within 4 hours of ingestion, given just prior to starting NAC 1
  • Draw blood for: acetaminophen level (if ≥4 hours post-ingestion), AST, ALT, INR, creatinine, BUN, electrolytes, and glucose 3, 2
  • If acetaminophen level is drawn before 4 hours post-ingestion, it is unreliable and must be repeated at 4 hours 1

NAC Dosing Regimens

Intravenous (20-hour protocol): 1

  • Loading dose: 150 mg/kg in 5% dextrose over 15 minutes
  • Second dose: 50 mg/kg over 4 hours
  • Third dose: 100 mg/kg over 16 hours

Oral (72-hour protocol): 1, 2

  • Loading dose: 140 mg/kg diluted to 5% solution
  • Maintenance: 70 mg/kg every 4 hours for 17 additional doses
  • The 72-hour oral regimen may be superior when treatment is delayed 1

Risk Stratification Using the Rumack-Matthew Nomogram

Use the nomogram ONLY for: 4, 1

  • Single acute ingestions with known time of ingestion
  • Acetaminophen levels drawn 4-24 hours post-ingestion

Administer NAC if: 4, 1

  • Acetaminophen level plots at or above the "possible toxicity" line (≥200 mcg/mL at 4 hours or ≥50 mcg/mL at 12 hours)
  • Level plots above the treatment line at any point between 4-24 hours

Do NOT use the nomogram for: 1

  • Presentations >24 hours post-ingestion
  • Extended-release formulations
  • Repeated supratherapeutic ingestions
  • Unknown time of ingestion

Special Clinical Scenarios Requiring NAC (Regardless of Nomogram)

Treat immediately with NAC if ANY of the following: 1

  • Hepatotoxicity already present: AST or ALT >50 IU/L with any detectable acetaminophen level 1
  • Severe hepatotoxicity: AST or ALT >1,000 IU/L (even without clear overdose history) 1
  • Acute liver failure: Elevated transaminases "in the thousands" with elevated bilirubin and INR 1
  • Unknown time of ingestion with detectable acetaminophen level 1
  • Extended-release acetaminophen: Obtain serial levels at 4 hours and again 4-6 hours later, as absorption continues beyond 8-14 hours and levels may rise late 5, 1
  • Repeated supratherapeutic ingestion: ≥10 g or 200 mg/kg in 24 hours, OR ≥6 g or 150 mg/kg per day for ≥48 hours 1
  • High-risk patients (chronic alcohol use, liver disease): Treat even with levels in "non-toxic" range, as hepatotoxicity occurs with doses as low as 4 g/day 1

Critical Timing and Efficacy Data

Treatment efficacy decreases dramatically with delay: 1

  • 0-8 hours: 2.9% develop severe hepatotoxicity
  • 8-10 hours: 6.1% develop severe hepatotoxicity
  • 10-24 hours: 26.4% develop severe hepatotoxicity
  • >24 hours: Still beneficial (reduces mortality from 80% to 52% in fulminant hepatic failure) but significantly less effective 1

When to Continue NAC Beyond Standard Protocol

Extend NAC treatment if: 1

  • Acetaminophen level remains detectable
  • AST or ALT is elevated or rising
  • Any coagulopathy (elevated INR)
  • Delayed presentation (>24 hours)
  • Extended-release formulation
  • Repeated supratherapeutic ingestion
  • Unknown time of ingestion

Continue NAC until: 1

  • Acetaminophen level is undetectable AND
  • AST/ALT are normal or declining AND
  • INR is normal

Management of Established Hepatotoxicity

If severe hepatotoxicity develops (AST/ALT >1,000 IU/L): 1

  • Continue or restart NAC immediately (reduces mortality from 80% to 52%) 1
  • Admit to ICU for monitoring of encephalopathy, coagulopathy, renal failure, and metabolic derangements 1
  • Contact liver transplant center immediately 1
  • Monitor AST, ALT, and INR every 4 hours until aminotransferases peak and decline 3

Common Pitfalls to Avoid

  • Do not wait for acetaminophen levels if ingestion occurred within 24 hours—start NAC immediately 2
  • Do not rely on a single 4-hour level for extended-release formulations—obtain a second level 4-6 hours later, as three patients in one series had initial levels below the treatment line that later rose above it 5
  • Do not stop NAC prematurely—verify acetaminophen is undetectable AND transaminases are normal/declining before discontinuing 1
  • Low or absent acetaminophen levels do not rule out poisoning if ingestion was remote or occurred over several days 1
  • Very high aminotransferases (>3,500 IU/L) are highly correlated with acetaminophen poisoning even without clear overdose history 3
  • If patient vomits oral NAC within 1 hour, repeat that dose 2
  • Chronic alcoholics require treatment even with "non-toxic" levels, as severe hepatotoxicity occurs with doses as low as 4-5 g/day 1

Monitoring During Treatment

  • Repeat AST, ALT, INR, creatinine, BUN, glucose, and electrolytes daily if acetaminophen level is in the potentially toxic range 2
  • Monitor AST, ALT, and INR every 4 hours if hepatotoxicity is developing 3
  • Add phosphate monitoring if acute liver failure develops 3

References

Guideline

Acetaminophen Overdose Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Laboratory Testing in Acetaminophen Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tylenol Extended Relief overdose.

Annals of emergency medicine, 1997

Related Questions

What is the treatment for an acetaminophen (Tylenol) overdose?
What is the treatment for acetaminophen (Tylenol) ingestion toxicity?
How soon can you re-administer Tylenol (acetaminophen) after a patient vomits?
What are the physical and diagnostic findings associated with acetaminophen (N-acetyl-p-aminophenol) ingestion?
What is the best course of action for a patient with a history of daily alcohol consumption and smoking, who presented with seizures, high-grade fever, and an unarousable state, following a fall on the back during a drinking spree, and has developed urinary retention with a distended bladder and impaired renal function, despite being medicated with Paracetamol (acetaminophen) and Dexamethasone?
What are the next steps for a patient recently restarted on clozapine (Clozapine) with normal troponin, creatine kinase (CK), and C-reactive protein (CRP) levels, but elevated creatine kinase-muscle band (CK-MB) levels?
What is the first-line antibiotic treatment for a patient with bacterial conjunctivitis, without any specified allergies or resistant bacterial infections?
What is the likely diagnosis and treatment for a smoker experiencing shortness of breath and wheezes?
What medication is recommended for a patient, particularly the elderly or those with impaired renal (kidney) or hepatic (liver) function, or a history of gastrointestinal disorders such as Irritable Bowel Syndrome (IBS) or Inflammatory Bowel Disease (IBD), experiencing frequent bowel movements?
Can an Epsom salt soak help alleviate gout pain in a patient, especially one with potential underlying medical conditions such as kidney disease or heart problems?
Can a patient with end-stage renal disease and potential comorbid conditions such as diabetes or hypertension leave tissue plasminogen activator (TPA) (alteplase) in their dialysis catheter for 24 hours?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.